(Q43912236)

28 November 2017

title

Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation (English)

1 reference

28 November 2017

1 reference

Algra A

1 reference

28 November 2017

Kemmeren JM

1 reference

28 November 2017

Grobbee DE

series ordinal

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Journal of Internal Medicine

28 November 2017

published in

1 reference

28 November 2017

volume

250

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

441-448

1 reference

Editorial: Oral contraceptives and myocardial infarction

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Oral contraceptives and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Hypertriglyceridaemia and hypercoagulability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Lipid metabolism effects with desogestrel-containing oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Effects on haemostasis variables by second and third generation combined oral contraceptives: a review of directly comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Lipid metabolism and coagulation of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

The triglyceride issue: a view from Framingham

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Effect of androgens on serum lipids and lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Case-control study of oral contraceptives and risk of thromboembolic stroke: results from international study on oral contraceptives and health of young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Metabolic changes during treatment with two different progestogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

Risk of acute myocardial infarction and low-dose combined oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2001.00906.X

10.1046/J.1365-2796.2001.00906.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference